San Jose, CA, United States of America

Amiel Richard Aguilar

This inventor holds 10 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Incumedx Inc., Arissa Medical, Inc., Boston Scientific Scimed, Inc.. Active years: 2011-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amiel Richard Aguilar. Retrieved from https://idiyas.com/inventor/amiel-richard-aguilar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 10 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2011-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of Amiel Richard Aguilar

Introduction: Amiel Richard Aguilar is a visionary inventor based in San Jose, California, known for his groundbreaking contributions to the field of technology and beyond.

Latest Patents: Amiel Richard Aguilar holds several patents in various technological domains, showcasing his versatility and creativity in innovation.

Career Highlights: With a career spanning over two decades, Aguilar has consistently pushed the boundaries of what is possible, with a focus on creating solutions that make a meaningful impact on society.

Collaborations: Throughout his career, Amiel Richard Aguilar has collaborated with leading tech companies, research institutions, and universities to bring his ideas to life and drive progress in the innovation landscape.

Conclusion: Amiel Richard Aguilar's passion for innovation, coupled with his relentless drive to create a better future through technology, solidifies his position as a pioneering inventor in the modern era.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…